CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops innovative contrast agents to enhance Magnetic Resonance Imaging (MRI) capabilities for studying brain diseases. It aims to improve the resolution and specificity of MRI in pre-clinical research through novel imaging techniques.
Magnetic Resonance Imaging (MRI) is a non-damaging and non-invasive imaging modality, with the abilities to effortlessly image the entire brain at any depth.
However, MRI provides images with low contrast and very poor resolution, and these are but an indirect description of features in the tissue (e.g., cells) because MRI images water protons.
These aspects limit the use of MRI in pre-clinical research settings (e.g., biomedical research) to study brain diseases.
Resultantly, pharmaceutical and…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.